Author Search Results :: UTM Library Massive Scholar Tracking

Pavel Klener

Klener in 2016

Pavel Klener (9 April 1937 – 20 September 2024) was a Czech oncologist and politician. A member of the Civic Forum and later the Civic Democratic Alliance, he served as Minister of Health and Social Affairs from 1989 to 1990 and was a member of the Czech National Council from 1990 to 1992.

In 2003, he received the Medal of Merit (second grade).

Klener died on 20 September 2024, at the age of 87. Provided by Wikipedia

1

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas by Robert Pytlik, Kamila Polgarova, Jana Karolova, Pavel Klener

Published 2020-11-01

Get full text

Article
2

Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report by Magdalena Klanova, Pavel Klener, Marek Trneny, Jan Straub, Ivan Spicka

Published 2012-01-01

Get full text

Article
3

Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells by Pavel Otáhal, Dana Průková, Vlastimil Král, Milan Fabry, Petra Vočková, Lucie Latečková, Marek Trněný, Pavel Klener

Published 2016-04-01

Get full text

Article
4

Second bone marrow transplantation into regenerating hematopoiesis enhances reconstitution of immune system by Kateřina Faltusová, Martin Báječný, Tomáš Heizer, Petr Páral, Chia-Ling Chen, Katarína Szikszai, Pavel Klener, Emanuel Nečas

Published 2024-06-01

Get full text

Article
5

Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events by Pavel Burda, Alzbeta Hlavackova, Vendula Polivkova, Nikola Curik, Adam Laznicka, Jitka Krizkova, Jiri Suttnar, Pavel Klener, Katerina Machova Polakova

Published 2024-10-01

Get full text

Article
6

Experimental model of primary intraocular lymphoma based on BALB/CaNn strain and A20 cells is optimal for investigational research by Eva Skrlova, Eva Uherkova, Aneta Klimova, Diana Malarikova, Petra Svozilkova, Petr Matous, Vit Herynek, Tomas Kucera, Pavel Klener, Jarmila Heissigerova

Published 2025-03-01

Get full text

Article
7

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma by Maria Patra-Kneuer, Gaomei Chang, Wendan Xu, Christian Augsberger, Michael Grau, Myroslav Zapukhlyak, Kristina Ilieva, Karin Landgraf, Doris Mangelberger-Eberl, Kasra Yousefi, Philipp Berning, Katrin S. Kurz, German Ott, Pavel Klener, Pavel Klener, Cyrus Khandanpour, Cyrus Khandanpour, Pedro Horna, Jürgen Schanzer, Stefan Steidl, Jan Endell, Christina Heitmüller, Georg Lenz

Published 2023-07-01

Get full text

Article
8

Hematopoiesis in patients with mature B-cell malignancies is deregulated even in patients with undetectable bone marrow involvement by Bokang Calvin Lenyeletse Maswabi, Jan Molinsky, Filipp Savvulidi, Tomas Zikmund, Dana Prukova, Diana Tuskova, Magdalena Klanova, Petra Vockova, Lucie Lateckova, Ludek Sefc, Jan Zivny, Marek Trneny, Pavel Klener

Published 2017-04-01

Get full text

Article
9

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion by Diana Malarikova, Radek Jorda, Kristyna Kupcova, Jana Senavova, Alexandra Dolnikova, Eva Pokorna, Dmitry Kazantsev, Kristina Nozickova, Dana Sovilj, Celine Bellanger, David Chiron, Ladislav Andera, Vladimir Krystof, Miroslav Strnad, Karel Helman, Magdalena Klanova, Marek Trneny, Ondrej Havranek, Pavel Klener

Published 2024-03-01

Get full text

Article
10

Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors by Lenka Daumova, Dmitry Manakov, Jiri Petrak, Dana Sovilj, Matej Behounek, Ladislav Andera, Ondrej Vit, Olga Souckova, Ondrej Havranek, Alex Dolnikova, Nicol Renesova, Liliana Tuskova, Lucie Winkowska, Nardjas Bettazova, Kristyna Kupcova, Marie Hubalek Kalbacova, Miriama Sikorova, Marek Trneny, Pavel Klener

Published 2025-02-01

Get full text

Article